SPCs for second medical use patents

The CJEU, Europe’s highest court, severely restricts availability of Supplementary Protection Certificates (SPCs) for products based on second medical use patents

Ulla Klinge reports On 9 July 2020, the Court of Justice of the European Union (CJEU) handed down its decision in Santen (C-673/18), holding that it is not possible to obtain an SPC for a product based on a marketing authorisation for a new...

Inspicos earns top rankings across international surveys

For the thirteenth consecutive year, Managing Intellectual Property has ranked Inspicos in Tier 1 among patent prosecution firms in Denmark. Four of Inspicos’ attorneys have been acclaimed as “IP Stars” by MIP. Inspicos has likewise been top ranked by IAM Patent 1000. IAM’s editors...

EPO hearings still affected

Update 4th August 2020 Operations at the EPO continue to be affected by the Covid-19 outbreak. With regard to upcoming oral proceedings, the EPO has informed as follows: Oral proceedings before Examining Divisions are being held by videoconferencing. All oral proceedings in opposition scheduled...

German ratification void – UK is out

The German Federal Constitutional Court has ruled today that the German Parliament’s approval of the Agreement on a Unified Patent Court is void, as it has not been approved by the Parliament with the required two-thirds majority. The Court dismissed the complaint with regard to...

Ed Farrington appointed as partner

We proudly announce that European Patent Attorney Ed Farrington is now a shareholder and partner at Inspicos P/S. Ed joined Inspicos as an associate in 2010. Ed specializes in opposition and appeal proceedings at the European Patent Office, and regularly represents clients at oral...